Mainz Biomed Q2 EPS $(0.56), Sales $248.94K
Portfolio Pulse from Benzinga Newsdesk
Mainz Biomed reported Q2 losses of $(0.56) per share and sales of $248.94K.
August 15, 2023 | 7:36 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Mainz Biomed reported Q2 losses of $(0.56) per share, which could negatively impact the stock price.
Mainz Biomed reported a loss in Q2, which is generally seen as negative by investors. This could lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100